https://www.bbbiotech.ch/all-en/all2026-02-20T09:57:11+01:00https://www.bbbiotech.ch/all-en/all/about-bb-biotech/why-invest-in-biotechnology2026-02-11T18:09:53+01:00https://www.bbbiotech.ch/all-en/all/about-bb-biotech/our-vision-mission2026-02-11T18:09:32+01:00https://www.bbbiotech.ch/all-en/all/about-bb-biotech/team2026-02-11T18:10:14+01:00https://www.bbbiotech.ch/all-en/all/investors/share-information2026-02-11T18:07:00+01:00https://www.bbbiotech.ch/all-en/all/investors/dividend-policy2026-02-11T18:08:51+01:00https://www.bbbiotech.ch/all-en/all/investors/share-buyback2026-02-11T18:07:34+01:00https://www.bbbiotech.ch/all-en/all/investors/corporate-governance2026-02-12T16:16:06+01:00https://www.bbbiotech.ch/all-en/all/investors/annual-general-meeting2026-02-04T13:07:17+01:00https://www.bbbiotech.ch/all-en/all/investors/corporate-calendar2026-02-12T16:18:23+01:00https://www.bbbiotech.ch/all-en/all/investors/contact2026-02-10T15:34:49+01:00https://www.bbbiotech.ch/all-en/all/portfolio/portfolio-overview2026-02-11T18:04:31+01:00https://www.bbbiotech.ch/all-en/all/portfolio/our-investments2026-02-20T07:31:02+01:00https://www.bbbiotech.ch/all-en/all/portfolio/investment-strategy2026-02-11T18:06:06+01:00https://www.bbbiotech.ch/all-en/all/reports2026-04-07T09:42:16+02:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/newsletter-anmelden2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/shareholders-at-bb-biotech-ags-agm-vote-in-favor-of-all-proposals-and-approve-the-dividend-of-chf-2-25-per-share2026-03-19T17:49:25+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/annual-report-2025-bb-biotech-delivers-strong-performance-and-portfolio-value-realization2026-02-20T06:43:23+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-2025-annual-report2026-02-20T06:43:23+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-preliminary-full-year-2025-results-and-dividend-proposal2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-closes-the-2025-fiscal-year-with-a-profit2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-q3-2025-portfolio-uebertrifft-benchmark-erste-anzeichen-einer-branchen-erholung2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report-q3-20252026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-to-be-included-in-the-spi-esg-index2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-q2-2025-outperforms-nasdaq-biotech-index-strong-usd-returns-currency-drag-in-chf2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report-Q2-20252026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-q1-2025-sharpened-portfolio-focus-amid-continued-market-volatility2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report-Q1-20252026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/shareholders-at-bb-biotech-ag-s-agm-vote-in-favor-of-all-proposals-and-approve-the-dividend-of-chf-1-80-per-share2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/annual-report-2024-bb-biotech-positions-for-structural-sector-recovery-amid-shifting-market-dynamics2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-2024-annual-report2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-preliminary-full-year-2024-results-and-dividend-proposal2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-closes-the-2024-fiscal-year-with-a-profit2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/strategic-reallocation-of-portfolio-assets-progressing2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report-Q3242026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/substantial-pipeline-progress-at-several-portfolio-companies-offsets-rate-related-market-volatility2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report-and-announces-a-new-head-of-its-investment-management-team2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-presents-solid-first-quarter-results-biotech-stock-market-impacted-by-shifting-views-on-interest-rates2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report-Q1242026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/shareholders-at-bb-biotech-ag-s-agm-vote-in-favor-of-all-proposals-and-approve-the-dividend-of-chf-2-00-per-share2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-2023-annual-report2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/end-of-year-biotech-equity-market-rally-m-and-a-and-end-of-rate-hike-cycle2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-financial-results-for-2023-and-changes-to-the-board-of-directors2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/biotech-equity-markets-in-flux-the-impact-of-rising-bond-yields-and-shifting-healthcare-policies2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report-92026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/delisting-from-borsa-italiana2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/sector-rotation-and-fund-outflows-weigh-on-biotech-stocks-but-positive-developments-allow-fund-raising-to-strengthen-industry2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report-82026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/lackluster-first-quarter-for-biotech-stocks2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report-72026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/shareholders-at-bb-biotech-ag-s-agm-vote-in-favor-of-all-proposals-and-approve-the-dividend-of-chf-2-85-per-share2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-2022-annual-report2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/divergent-biotech-equity-markets-mirror-value-over-growth-theme-in-2022-proposed-dividend-of-chf-2-852026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-closes-the-2022-fiscal-year-with-a-loss2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/us-drug-pricing-legislation-drives-biotech-business-to-adapt-for-further-innovation2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report-62026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/first-signs-of-increased-m-and-a-activity-due-to-attractive-valuations2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report-52026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/increased-investment-level-balanced-by-established-core-holdings2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report-42026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-concludes-its-share-buyback-program-and-launches-a-new-buyback-program2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/shareholders-at-bb-biotech-ag-s-agm-vote-in-favor-of-all-proposals-approve-the-dividend-of-chf-3-85-per-share-and-elect-two-new-board-members2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-2021-annual-report2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/2021-was-a-difficult-year-for-biotech-equity-markets-increased-dividend-of-chf-3-85-proposed2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-closes-the-2021-fiscal-year-with-a-loss2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-increases-positions-in-oncology-and-cns2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-interim-report2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/solid-second-quarter-for-the-biotech-industry2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-interim-report-12026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/sector-re-valuation-used-for-portfolio-investments2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-interim-report-22026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/shareholders-at-bb-biotech-ag-s-agm-approve-all-proposals2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-2020-annual-report2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/vaccines-leading-the-way-out-of-the-pandemic2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-closes-the-2020-fiscal-year-with-a-profit2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/biotech-m-and-a-picks-up2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-interim-report-32026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/innovative-biotech-companies-lead-efforts2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/resilient-biotech-sector-despite-widespread-market-turmoil2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report-12026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/coronavirus-ist-primaer-kein-investment-case-in-german2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/shareholders-at-bb-biotech-ag-s-agm-vote-in-favor-of-all-proposals2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-2019-annual-report2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-benefits-from-m-and-a-transactions2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-closes-the-2019-fiscal-year-with-a-profit2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/expansion-of-the-board-of-directors2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/political-factors-weigh-on-biotech-equity-markets2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report-22026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/consolidation-leaves-a-mark-on-results2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-interim-report-32026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/strong-1st-quarter-for-bb-biotech2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-reports-results2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/completion-of-the-current-share-buyback-program2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/results-annual-general-meeting2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-publishes-its-2018-annual-report2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/starker-jahresauftakt-fuer-die-biotechbranche2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-invests-gains-of-m-and-a-transactions-in-new-technologies2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/bb-biotech-ag-closes-the-2018-fiscal-year-with-a-loss2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/media-insights/corporate-news/rivus-pharmaceuticals-closes-132-million-series-b-financing-to-advance-hu6-for-the-treatment-of-obesity-and-cardio-metabolic-disorders2026-02-10T16:12:52+01:00https://www.bbbiotech.ch/all-en/all/insights2026-02-10T16:05:32+01:00https://www.bbbiotech.ch/all-en/all/insights/newsletter2022-01-03T17:57:05+01:00https://www.bbbiotech.ch/all-en/all/insights/bb-biotech-investment-trust-review-highlights-long-term-success2022-01-06T16:39:33+01:00https://www.bbbiotech.ch/all-en/all/insights/video-update-bb-biotech-q1-20212022-01-06T15:40:10+01:00https://www.bbbiotech.ch/all-en/all/insights/cancer-medicine-improves-the-chances-of-a-cure2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/the-fundamentals-of-biotech-have-never-been-stronger2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/interview-with-daniel-koller2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/market-commentary-underestimated-newcomers2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/bb-biotech-q1-2022-update2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/biotech-sector-sees-potential-for-growth-post-covid2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/market-commentary-disruptive-technologies-are-changing-an-entire-industry2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/coveted-drivers-of-innovation2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/coveted-drivers-of-innovation-12026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/video-update-bb-biotech-q2-20222022-08-02T10:03:34+02:00https://www.bbbiotech.ch/all-en/all/insights/rising-m-and-a-activity-has-livened-up-the-biotech-sector2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/moderna-was-just-the-beginning2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/interview-edison-group-with-dr-daniel-koller2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/biotech-m-rna-and-genome-editing2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/molecular-strike-force-for-the-immune-system2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/bb-biotech-executive-interview2026-02-12T08:57:41+01:00https://www.bbbiotech.ch/all-en/all/insights/biotech-sector-to-take-off-in-20232026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/creating-blockbuster-drugs-using-algorithms2023-05-05T10:39:01+02:00https://www.bbbiotech.ch/all-en/all/insights/investment-opportunities-in-biotechnology2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/central-banks-catch-their-breath-will-biotech-shine-again-as-rates-stop-rising2023-09-28T16:28:38+02:00https://www.bbbiotech.ch/all-en/all/insights/bb-biotechs-koller-this-crash-will-look-like-a-blip2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/using-big-data-and-ai-to-find-tomorrow-s-biotech-leaders2026-02-12T09:10:25+01:00https://www.bbbiotech.ch/all-en/all/insights/daniel-koller-three-decades-of-biotech-evolution2026-02-12T09:05:53+01:00https://www.bbbiotech.ch/all-en/all/insights/bb-biotechs-dr-daniel-koller-discusses-the-funds-investment-strategy-and-performance2026-02-12T09:05:53+01:00https://www.bbbiotech.ch/all-en/all/insights/bb-biotech-video-update-insights-highlights-and-outlook2024-02-07T08:44:00+01:00https://www.bbbiotech.ch/all-en/all/insights/investor-interest-returns-dividend-yield-remains-high-for-20242026-02-12T09:05:53+01:00https://www.bbbiotech.ch/all-en/all/insights/new-study-in-nature-computational-science2026-02-12T08:57:41+01:00https://www.bbbiotech.ch/all-en/all/insights/resilience-amidst-uncertainty-in-biotech-a-q-a-with-bb-biotechs-dr-daniel-koller2026-02-12T09:05:53+01:00https://www.bbbiotech.ch/all-en/all/insights/conversations-with-panmure-gordon2026-02-12T09:05:53+01:00https://www.bbbiotech.ch/all-en/all/insights/investing-in-fast-growing-biotechnology-companies-with-bb-biotechs-dr-daniel-koller2026-02-12T09:05:53+01:00https://www.bbbiotech.ch/all-en/all/insights/the-impact-of-algorithms-and-big-data-on-drug-discovery-and-development-processes-an-empirical-study2026-02-12T09:05:53+01:00https://www.bbbiotech.ch/all-en/all/insights/argenx-in-the-spotlight2026-02-12T09:05:53+01:00https://www.bbbiotech.ch/all-en/all/insights/interview-edison-group-with-dr-christian-koch2026-02-12T09:05:53+01:00https://www.bbbiotech.ch/all-en/all/insights/bb-biotech-a-key-milestone-with-significance-for-the-sector2026-02-12T08:57:41+01:00https://www.bbbiotech.ch/all-en/all/insights/fresh-momentum-in-the-biotech-sector-good-entry-points2026-02-12T09:03:42+01:00https://www.bbbiotech.ch/all-en/all/insights/bb-biotech-staying-the-course-amid-market-volatility2026-02-12T09:03:42+01:00https://www.bbbiotech.ch/all-en/all/insights/low-valuations-looming-deals-why-bb-biotech-sees-new-cycle2026-02-12T09:03:42+01:00https://www.bbbiotech.ch/all-en/all/insights/what-pfizers-deal-with-donald-trump-means-for-global-drug-pricing2025-10-15T12:22:49+02:00https://www.bbbiotech.ch/all-en/all/insights/fourth-m-a-transaction-highlights-portfolio-strength2026-02-12T09:03:42+01:00https://www.bbbiotech.ch/all-en/all/insights/turning-milestones-into-momentum2026-02-12T09:03:42+01:00https://www.bbbiotech.ch/all-en/all/insights/executive-interview-with-edison-tv2026-02-12T09:02:17+01:00https://www.bbbiotech.ch/all-en/all/insights/bb-biotech-2025-video-update2026-02-20T09:37:26+01:00https://www.bbbiotech.ch/all-en/all/insights/from-innovation-to-value-realization-the-biotech-market-in-a-new-phase2026-02-24T14:19:05+01:00https://www.bbbiotech.ch/all-en/all/insights/why-biotech-is-becoming-attractive-to-investors-again2026-03-19T15:50:05+01:00https://www.bbbiotech.ch/all-en/all/insights/bb-biotech-active-management-across-the-biotechnology-value-chain2026-03-19T15:46:12+01:00https://www.bbbiotech.ch/all-en/all/praesentationen-events2026-02-12T09:58:08+01:00https://www.bbbiotech.ch/all-en/all/disclaimer2026-02-11T10:26:41+01:00https://www.bbbiotech.ch/all-en/all/data-protection2021-12-03T11:38:14+01:00https://www.bbbiotech.ch/all-en/all/conditions-of-use2022-02-16T13:45:36+01:00https://www.bbbiotech.ch/all-en/all/forbidden2026-02-12T09:58:08+01:00https://www.bbbiotech.ch/all-en/all/forbidden-usa2026-02-12T09:58:08+01:00https://www.bbbiotech.ch/all-en/all/forbidden-sgp2026-02-12T09:58:08+01:00https://www.bbbiotech.ch/all-en/all/cookie-box2021-11-25T15:30:50+01:00https://www.bbbiotech.ch/all-en/all/notfound2026-02-12T09:58:08+01:00https://www.bbbiotech.ch/all-en/all/header-navigation2026-02-08T20:16:31+01:00